HGERS
ABCL icon

Householder Group Estate & Retirement Specialist’s AbCellera Biologics ABCL Stock Holding History

Householder Group Estate & Retirement Specialist’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-500
Closed -$2K – 1273
2023
Q4 		$2K Buy
+500
New +$2.32K ﹤0.01% 974

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FFVM
Founders Fund VII Management San Francisco, California $2.03M AUM 72.34% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Householder Group Estate & Retirement Specialist's ABCL Position: Q1 2024 in Review

Householder Group Estate & Retirement Specialist sold out of AbCellera Biologics (ABCL) in Q1 2024, closing a stake of 500 shares — an estimated $2K sold.

Householder Group Estate & Retirement Specialist first reported a position in ABCL in Q4 2023 and held it in 1 quarter. The position peaked at $2K in Q4 2023. 154 funds tracked by Wall St. Rank hold ABCL as of Q1 2024.

  • Householder Group Estate & Retirement Specialist reported no remaining AbCellera Biologics position as of Q1 2024 after selling out during the quarter.
  • Householder Group Estate & Retirement Specialist sold 500 AbCellera Biologics shares in Q1 2024, an estimated $2K.
  • Householder Group Estate & Retirement Specialist first reported a position in AbCellera Biologics in Q4 2023 and held it in 1 quarter.
  • Householder Group Estate & Retirement Specialist's AbCellera Biologics position peaked at $2K in Q4 2023.
  • 154 funds tracked by Wall St. Rank held AbCellera Biologics as of Q1 2024.

Based on Householder Group Estate & Retirement Specialist's 13F filing for Q1 2024, filed 3 May 2024.